Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Biliary Tract Diseases

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    August 2017
  1. NAKAJIMA A, Seki M, Taniguchi S
    Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    J Gastroenterol. 2017 Aug 24. doi: 10.1007/s00535-017-1383.
    PubMed     Text format     Abstract available


    April 2017
  2. FLOREANI A, Tanaka A, Bowlus C, Gershwin ME, et al
    Geoepidemiology and changing mortality in primary biliary cholangitis.
    J Gastroenterol. 2017 Apr 1. doi: 10.1007/s00535-017-1333.
    PubMed     Text format     Abstract available


    December 2016
  3. TAZUMA S, Unno M, Igarashi Y, Inui K, et al
    Evidence-based clinical practice guidelines for cholelithiasis 2016.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  4. NAKAZAWA T, Notohara K, Tazuma S, Tanaka A, et al
    The 2016 diagnostic criteria for primary sclerosing cholangitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  5. UMEFUNE G, Kogure H, Hamada T, Isayama H, et al
    Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  6. KAMISAWA T, Kuruma S, Chiba K, Tabata T, et al
    Biliary carcinogenesis in pancreaticobiliary maljunction.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  7. OZAWA N, Yasuda I, Doi S, Iwashita T, et al
    Prospective randomized study of endoscopic biliary stone extraction using either a basket or a balloon catheter: the BasketBall study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  8. MOON SH, Kim MH, Lee JK, Baek S, et al
    Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  9. SHODA J, Matsuda A, Shida T, Yamamoto M, et al
    Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  10. YAMADA N, Sanada Y, Tashiro M, Hirata Y, et al
    Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  11. TANAKA A, Takikawa H, Mochida S, Koike K, et al
    Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".
    J Gastroenterol. 2016.
    PubMed     Text format    


    April 2016
  12. SUGIYAMA A, Kanno K, Nishimichi N, Ohta S, et al
    Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via alpha integrin interaction.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  13. SOROIDA Y, Sato M, Hikita H, Hagiwara S, et al
    Pancreatic cysts in general population on ultrasonography: Prevalence and development of risk score.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  14. ZEN Y, Kawakami H, Kim JH
    IgG4-related sclerosing cholangitis: all we need to know.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2015
  15. MOHRI D, Ijichi H, Miyabayashi K, Takahashi R, et al
    A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  16. OKUSHIN K, Tsutsumi T, Enooku K, Fujinaga H, et al
    The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  17. KOMAYA K, Ebata T, Fukami Y, Sakamoto E, et al
    Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  18. DEGIORGIO D, Crosignani A, Colombo C, Bordo D, et al
    ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  19. OKUNO M, Ebata T, Yokoyama Y, Igami T, et al
    Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  20. UMEDA J, Itoi T
    Current status of preoperative biliary drainage.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  21. ITATSU K, Yokoyama Y, Ebata T, Igami T, et al
    The value of preoperative screening colonoscopies in patients with biliary tract cancer.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    June 2014
  22. TATEISHI R, Okanoue T, Fujiwara N, Okita K, et al
    Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: